Atul R Mahableshwarkar

Summary

Publications

  1. doi request reprint A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder
    Atul R Mahableshwarkar
    Takeda Global Research and Development Center, One Takeda Parkway, Deerfield, IL 60015, USA
    Curr Med Res Opin 29:217-26. 2013
  2. pmc Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
    Mohammed Y Alam
    aAmerican Medical Research Inc, Oak Brook bTakeda Development Center Americas, Deerfield, Illinois, USA
    Int Clin Psychopharmacol 29:36-44. 2014
  3. doi request reprint A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder
    Atul R Mahableshwarkar
    Takeda Development Center Americas, Deerfield, Illinois, USA
    Hum Psychopharmacol 29:64-72. 2014

Collaborators

  • Mohammed Y Alam
  • Michael Serenko
  • Yinzhong Chen
  • Paula L Jacobsen

Detail Information

Publications3

  1. doi request reprint A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder
    Atul R Mahableshwarkar
    Takeda Global Research and Development Center, One Takeda Parkway, Deerfield, IL 60015, USA
    Curr Med Res Opin 29:217-26. 2013
    ..This trial assessed the efficacy and tolerability of 2.5 and 5 mg vortioxetine for the treatment of MDD...
  2. pmc Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
    Mohammed Y Alam
    aAmerican Medical Research Inc, Oak Brook bTakeda Development Center Americas, Deerfield, Illinois, USA
    Int Clin Psychopharmacol 29:36-44. 2014
    ..2 at week 52 (from 17.6 at open-label baseline) in the observed case data set. ..
  3. doi request reprint A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder
    Atul R Mahableshwarkar
    Takeda Development Center Americas, Deerfield, Illinois, USA
    Hum Psychopharmacol 29:64-72. 2014
    ..Vortioxetine is a recently approved multimodal antidepressant with anxiolytic properties in preclinical studies...